BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31828868)

  • 1. MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis.
    Pourhanifeh MH; Mahjoubin-Tehran M; Shafiee A; Hajighadimi S; Moradizarmehri S; Mirzaei H; Asemi Z
    IUBMB Life; 2020 Mar; 72(3):314-333. PubMed ID: 31828868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.
    Raimondi L; De Luca A; Morelli E; Giavaresi G; Tagliaferri P; Tassone P; Amodio N
    Biomed Res Int; 2016; 2016():6504593. PubMed ID: 26881223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
    Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
    J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of exosomes in multiple myeloma.
    Moloudizargari M; Abdollahi M; Asghari MH; Zimta AA; Neagoe IB; Nabavi SM
    Blood Rev; 2019 Nov; 38():100595. PubMed ID: 31445775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal mRNAs and lncRNAs involved in multiple myeloma resistance to bortezomib.
    Tang JX; Chen Q; Li Q; He YH; Xiao D
    Cell Biol Int; 2021 May; 45(5):965-975. PubMed ID: 33372728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
    Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
    Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment.
    Tian X; Sun M; Wu H; Chen C; Li H; Qiu S; Wang T; Han J; Xiao Q; Chen K
    Leuk Res; 2021 Jun; 105():106566. PubMed ID: 33848709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs.
    Raimondi L; De Luca A; Gallo A; Costa V; Russelli G; Cuscino N; Manno M; Raccosta S; Carina V; Bellavia D; Conigliaro A; Alessandro R; Fini M; Conaldi PG; Giavaresi G
    Carcinogenesis; 2020 Jul; 41(5):666-677. PubMed ID: 31294446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow stromal cells derived exosomal miR-10a and miR-16 may be involved in progression of patients with multiple myeloma by regulating EPHA8 or IGF1R/CCND1.
    Peng Y; Song X; Lan J; Wang X; Wang M
    Medicine (Baltimore); 2021 Jan; 100(4):e23447. PubMed ID: 33530159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
    Wang J; De Veirman K; De Beule N; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E
    Oncotarget; 2015 Dec; 6(41):43992-4004. PubMed ID: 26556857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.
    Wang J; De Veirman K; Faict S; Frassanito MA; Ribatti D; Vacca A; Menu E
    J Pathol; 2016 Jun; 239(2):162-73. PubMed ID: 26956697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncoding RNAs in the crosstalk between multiple myeloma cells and bone marrow microenvironment.
    Tang W; Xu J; Xu C
    Cancer Lett; 2023 Mar; 556():216081. PubMed ID: 36739065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of miRNA dysregulation in the pathogenesis of multiple myeloma.
    Chen D; Yang X; Liu M; Zhang Z; Xing E
    Cancer Gene Ther; 2021 Dec; 28(12):1256-1268. PubMed ID: 33402729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.
    Amodio N; Leotta M; Bellizzi D; Di Martino MT; D'Aquila P; Lionetti M; Fabiani F; Leone E; Gullà AM; Passarino G; Caraglia M; Negrini M; Neri A; Giordano A; Tagliaferri P; Tassone P
    Oncotarget; 2012 Oct; 3(10):1246-58. PubMed ID: 23100393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.
    Soley L; Falank C; Reagan MR
    Curr Osteoporos Rep; 2017 Jun; 15(3):162-170. PubMed ID: 28432594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma.
    Wang J; Faict S; Maes K; De Bruyne E; Van Valckenborgh E; Schots R; Vanderkerken K; Menu E
    Oncotarget; 2016 Jun; 7(25):38927-38945. PubMed ID: 26950273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microenvironment drug resistance in multiple myeloma: emerging new players.
    Di Marzo L; Desantis V; Solimando AG; Ruggieri S; Annese T; Nico B; Fumarulo R; Vacca A; Frassanito MA
    Oncotarget; 2016 Sep; 7(37):60698-60711. PubMed ID: 27474171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma.
    Alipoor SD; Chang H
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance.
    Desantis V; Saltarella I; Lamanuzzi A; Melaccio A; Solimando AG; Mariggiò MA; Racanelli V; Paradiso A; Vacca A; Frassanito MA
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.